Saverio Cinieri
Overview
Explore the profile of Saverio Cinieri including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
185
Citations
1915
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Leone A, Bonadonna S, Cassani C, Barcellini A, Sirico M, Tagliaferri B, et al.
BMJ Oncol
. 2025 Jan;
3(1):e000330.
PMID: 39886120
Transgender and gender-diverse (TGD) individuals face an elevated risk of cancer in comparison with the general population. This increased risk is primarily attributed to an imbalanced exposure to modifiable risk...
2.
Zagami P, Esposito A, Taurelli Salimbeni B, Berton Giachetti P, Scafetta R, Lambertini M, et al.
Breast
. 2025 Jan;
79:103875.
PMID: 39826385
Purpose: CDK4/6 inhibitors (CDK4/6i) use has revolutionized the treatment of hormone receptor-positive/human epidermal growth factor receptor 2 negative (HR+/HER2-) metastatic breast cancer. The choice of a specific CDK4/6i may be...
3.
Montegut C, Falandry C, Cinieri S, Cropet C, Montane L, Rousseau F, et al.
Oncologist
. 2024 Dec;
PMID: 39673779
Background: In PAOLA-1/ENGOT-ov25, the addition of olaparib to bevacizumab maintenance improved overall survival in patients with newly diagnosed advanced ovarian cancer. We describe the safety profile and quality of life...
4.
Kime A, Bataillon G, Treilleux I, Callens C, Selle F, Heitz F, et al.
Arch Pathol Lab Med
. 2024 Dec;
PMID: 39648143
Context.—: A correlation between the morphology of ovarian high-grade serous carcinomas (HGSOCs) and BRCA mutations has been previously reported. Objective.—: To investigate, beyond BRCA, the association between the morphology of...
5.
Saporita I, Calabrese M, Poletto S, Turco F, Di Stefano R, Caffo O, et al.
Clin Genitourin Cancer
. 2024 Nov;
23(1):102255.
PMID: 39615118
Background: 20% of prostate cancer (PC) patients harbor germinal or somatic alterations in homologous recombination repair (HRR) genes, including BRCA1/2. BRCA mutations represent predictive biomarkers for treatment with polyadenosine diphosphate-ribose...
6.
Silvestris N, Aprile G, Tessitore D, Mentrasti G, Petrella M, Speranza D, et al.
Crit Rev Oncol Hematol
. 2024 Nov;
206:104571.
PMID: 39581244
Cancer is currently one of the biggest public health challenges worldwide, ranking as the second leading cause of death globally. To date, strong epidemiological associations have been demonstrated between unhealthy...
7.
Indraccolo S, Signoriello S, Piga I, Esposito G, Ferrarini F, Boscolo Bragadin A, et al.
Int J Biol Markers
. 2024 Nov;
39(4):328-337.
PMID: 39513196
Introduction: In ovarian cancer, expression of metabolism-related markers has been investigated in several studies focusing on individual markers; however, a parallel quantitative evaluation of markers mapping to distinct metabolic processes...
8.
Iacovino M, Celant S, Tomassini L, Arenare L, Caglio A, Canciello A, et al.
Lancet Reg Health Eur
. 2024 Oct;
44:101012.
PMID: 39444700
[This retracts the article DOI: 10.1016/j.lanepe.2024.100973.].
9.
Galvano A, Gottardo A, Gristina V, Fanale D, Corsini L, Pavone C, et al.
Crit Rev Oncol Hematol
. 2024 Oct;
204:104531.
PMID: 39427840
The communication of scientific knowledge to patients and society as a whole has never been more central than in modern times. Thanks to the recent pandemic, it has become evident...
10.
Panzuto F, Albertelli M, De Rimini M, Rizzo F, Grana C, Cives M, et al.
J Endocrinol Invest
. 2024 Oct;
48(1):23-36.
PMID: 39395114
Purpose: This paper outlines the consensus of the Italian Association for Neuroendocrine Tumors(Itanet), the Italian Association of Nuclear Medicine (AIMN), the Italian Society of Endocrinology (SIE), and the Italian Association...